What is precision psychiatry? Insights from Universal Brain
admin Outsourcing Pharma had the opportunity to speak with Kazu Okuda, MD, CEO, and co-founder of Universal Brain, about…
Medicine
Women in Science – Ann Graham from fighting cancer to helping kids
Finding herself on a pediatric ward something inside her changed and she became determined to do something to…
Skye and Beacon collaborate on sleep apnea in obesity trial
As Skye embarks on their CBeyond phase 2 clinical trial, we explore the motivation, methodology, and expected outcomes…
Red Queen launches to tackle viral infections
Backed by a $55 million Series A funding round from Apple Tree Partners (ATP) and a contract with…
FDA poised to decide on Lykos’ MDMA therapy for PTSD
This decision follows a mixed response from the FDA advisory committee, which voted against recommending the treatment. However,…
Skye and Beacon collaborate on sleep pnea in obesity trial
As Skye embarks on their CBeyond phase 2 clinical trial, we explore the motivation, methodology, and expected outcomes…
pharmacovigilance with AI and innovation
James, who joined Qinecsa three years ago after stints at Genpact and Accenture, discussed the company’s mission, products,…
Strategies for CDMOs to prepare for the 2032 BioSecure Act
This article features insights from leading experts at CAI, including Alice Redmond, Harry Benson, Jonathan Thompson, and David…
AI tool enhances drug discovery for age-related diseases
The organizations say this collaboration uses the strengths of both to create a cutting-edge platform designed to uncover…
Bateman Horne Center advances ME/CFS and long COVID care
As a 501(c)(3) nonprofit organization, BHC has made significant strides in addressing chronic health challenges that affect millions…
Oxford experts unveil breakthrough online therapies for anxiety and PTSD
These internet-based solutions are designed to support patients with social anxiety disorder, post-traumatic stress disorder (PTSD), and anxiety…
Women in Science – Ann Graham from fighting cancer to helping kids
Finding herself on a pediatric ward something inside her changed and she became determined to do something to…
Piramal Pharma Solutions surpasses revenue milestone in innovation
For the first time, revenue earned from innovation programs has surpassed that from generic projects. Over the past…
Shaping the future of clinical trials through data and AI
Clark highlights several key trends and advancements shaping the industry today. The explosion of data and complexity Clark…
Understanding the impact of ICH E6(R3) on clinical research
The E6(R3) Guideline for Good Clinical Practice revises ICH E6(R2) and is expected to go live in 2025.…
Challenges and strategies in parenteral drug development at Lonza
To gain insight into this complex landscape, we spoke with Abbas Razvi, head of pharmaceutical development, and Sandro…
Women in Science: Deep Genomics’ Tehmina Masud
With an inquisitive mind and by asking endless questions, she soon found herself studying medicine and fully understanding…
$2 Million in grants awarded to tackle neurodegenerative diseases
This funding will be distributed over two years to four pioneering research projects that emerged from the Tauopathy…
EU rejects lecanemab for Alzheimer’s treatment
On Friday (July 26), the European Union’s drugs regulator, the Committee for Medicinal Products for Human Use (CHMP),…
Next-gen mobile technologies transform clinical research
By creating a future of cheaper and faster studies, these innovations are paving the way for more targeted…
More power to the pharmacists or is the extra work too much?
The move was made to help free up access to care for patients across pharmacies and dental practices…
IQVIA’s One Home – streamlining clinical research tech
This SaaS-based solution simplifies the workflow for clinical trial site staff, enabling them to focus more on patient…
Donanemab approval – a new era for Alzheimer’s treatment
At the Alzheimer’s Association International Conference, experts from the Emmes Group discussed the impact of this new therapy…
pharmacovigilance with AI and innovation
Bellamy, who joined Qinecsa three years ago after stints at Jam Packs and Accenture, discussed the company’s mission,…
Cure51 co-founders on changing cancer treatment
In this exclusive interview, they share insights into their mission to decode exceptional cancer survival cases, their innovative…
Agilent snaps up biologics CDMO BIOVECTRA
The deal, which was financed by cash and debt financing, is due to close before 2025 and will…
Third Arc Bio to run multiple programs in 2025 thanks to funding
Third Arc Bio has announced the closing of a $165 million series A round led by Vida Ventures…
Inspiring women in science: Laura Child’s journey
Her journey in life sciences began with a deep childhood curiosity about the natural world, leading to a…
Women in Science: Neurologist Antonella Favit-VanPelt
From asking endless questions about the causes of illness as a young girl to pioneering therapeutic innovations as…
ViiV Healthcare reports positive data on Apretude use during pregnancy
The findings come from the HIV Prevention Trials Network (HPTN) 084 open label extension (OLE) study, which evaluated…
Celadon completes eighth harvest, on track for 15 in 2024
This accomplishment highlights the company’s creative approach and steady march towards completing 15 harvests within the calendar year.…
Pharmacists’ key role in liver health and disease prevention
Her leadership encompasses visionary support, development, and advocacy for FIP’s 144 member organizations, representing four million members globally.…
JOGO Health collaborates with Mayo Clinic to study tremors
This partnership aims to revolutionize the understanding and treatment of various tremor conditions, using the combined expertise of…
GLP-1 drug demand sees €900M investment from CordenPharma
The expansion will cover existing facilities as well as brand new constructions. CordenPharma aims for all its facilities…
Roche announces good early results for oral GLP-1 receptor agonist
Genentech, a Roche Group member, announced this week that its investigational oral, glucagon-like peptide-1 (GLP-1) receptor agonist CT-996…
The top 5 CDMOs developing advanced therapies
The manufacturing and regulatory process of biopharmaceuticals is highly complex and costly to implement, which can be challenging…
Avista and Hamilton Lane partner to grow Cosette Pharmaceuticals
The companies will jointly control Cosette, with a focus on accelerating innovation and growth. Since Avista’s initial investment…
FDA approves Voquenza for non-erosive GERD treatment
This marks the third FDA approval for Voquenza, which is also approved for treating all severities of Erosive…
Caroline Shleifer: Leading AI-driven regulatory intelligence
She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare,…
Marwan Fathallah’s vision for DIA, the future of healthcare innovation
With an impressive career spanning 35 years in the healthcare industry, Fathallah shares his vision for the future…
Nipro Invests $397.8M in NC, creating 232 jobs in Pitt County
This significant project is set to create 232 jobs in Pitt County and marks a milestone in Nipro’s…
IDT expands synthetic biology facility to boost capacity
This state-of-the-art facility not only doubles IDT’s production capacity but also introduces cutting-edge technologies and energy-efficient measures to…
Transforming healthcare with a data-driven focus
By leveraging diverse data sources and advanced analytics, the company says it empowers the healthcare continuum to make…
Celadon completes eighth harvest, on track for 15 in 2024
This accomplishment highlights the company’s creative approach and steady march towards completing 15 harvests within the calendar year.…
The top 5 startups developing psychedelic drugs
Investment in psychedelic drugs started booming in 2020. The lockdowns brought by the Covid-19 pandemic highlighted the importance…
An Interview with Tim Martin of Yseop
In an insightful interview, Tim Martin, vice president, product, at Yseop, discusses the company’s recent advancements, notable collaborations,…
How does Leal Health’s GenAI transform cancer patient care?
This innovation is poised to transform patient access to cancer care by leveraging advanced AI capabilities to provide…
How is wearable tech enhancing sleep tracking in clinical trials?
Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose…
Tyra Biosciences announces proof of concept data in hypochondroplasia
Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate,…
Vox Pop Pharma – where will AI be in five years?
Industry leaders give their takes on what else is in store for AI-based tools in the pharma space.…
CEO discusses hormone-free male birth control development
Bakshi shares the innovative approach of YCT-529, the results of their Phase 1a study, and the anticipated impact…
Unlocking innovation: Women in Science
In this interview, she shares insights into her role, personal journey, challenges faced, and advice for aspiring women…
Barriers to opioid treatment access in the US
This Q&A with Sheeba Ibidunni, public health expert and the VP of operations at Sonara Health explores the…
Unveiling a key player in ovarian cancer survival
The initiative seeks to understand the crucial role of the omentum, a lesser-known yet vital organ in cancer…
dsm-firmenich unveils advanced CBD drug product intermediate
The IP-protected CBD intermediate brings superior functionality allowing for a higher drug loading compared to currently commercially available…
Women in Science – Vector Labs’ Pam James
With a lot of familial inspiration, an early love of science developed for Pam James, here we find…
How does the FDA’s Accelerated Approval Program impact patients?
Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law,…
Eli Lilly enters $140M partnership with Radionetics Oncology
Eli Lilly has entered a strategic partnership with Radionetics Oncology, a biotechnology company focusing on the discovery and…
CatSci acquires Reach Separations to offer chromatography services
The deal was supported by Keensight Capital, a private equity manager focusing on pan-European investments in the technology…
Tyra Biosciences announces proof of concept data in hypochondroplasia
Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate,…
How is wearable tech enhancing sleep tracking in clinical trials?
Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose…
Esteve invests €100 million in Spanish API manufacturing muscle
The construction project will be financed until 2026 by a €100 million ($108 million) investment by the company.…
ALS treatment slows down disease progression by 36%
Results from the PARADIGM clinical trial have revealed that PrimeC, a treatment being developed by NeuroSense Therapeutics, was…
ELRIG UK & The Protein Society host drug discovery conference
This collaboration aims to unite experts from various fields to explore how emerging protein science can address the…
Revolutionizing clinical trials: Yonalink’s game-changing tech
YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior…
The evolution of personalized medicine for reproductive health
Also known as precision medicine, this kind of individualized treatment is designed specifically for the patient and has…
The pharma industry’s commitment to sustainability
These efforts are driven by the need for transparency, compliance, and sustainability in response to pressures from stakeholders,…
FDA greenlights Verona’s game-changing COPD drug Ohtuvayre
This groundbreaking approval is expected to transform the market for patients suffering from moderate to severe exacerbations, particularly…
The top 5 emerging startups fuelling drug discovery with AI
Check out five upcoming AI players attracting investor attention for their potential to speed up drug discovery. Drug…
Revolutionizing clinical trials: Yonalink’s game-changing tech
YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior…
Mainz Biomed’s cancer stool test takes on liquid biopsies
In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for…
Will Novo Nordisk’s $4.1BN US investment transform drug manufacturing?
This expansion, one of the largest in the company’s history, aims to enhance the production of injectable treatments…
How does the FDA’s Accelerated Approval Program impact patients?
Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law,…
CluePoints’ growth investment from EQT: What’s next?
CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical…
EMA’s new clinical trials guideline
This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9…
Is behavioral science key to patient-focused drug development?
Last year, Astellas Pharma established a behavioral science consortium to perform research aimed at better understanding what matters…
Deep dive – why did IQVIA launch a participant payments service?
IQVIA recognized the intricate challenges associated with participant payments in clinical trials, which often involve cumbersome processes and…
How will Cellibre’s $2M NIH grant revolutionize pharma production?
This first-of-its-kind phase 2 grant will expedite the commercialization of cannabinoid ingredient production via precision fermentation. The funding…
Mainz Biomed’s cancer stool test takes on liquid biopsies
In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for…
How are AI and real-world data speeding up drug development?
The panel featured Ariel Berger, executive director of integrated solutions and real-world evidence at Aventura; John Van Hoy,…
Sonara Health’s innovative app enhancing access to methadone treatment
With his background in psychiatry, Michael observed the daily struggles of patients in Opioid Treatment Programs and developed…
DSP Expansion Adds 200,000 sq.ft. to Boost R&D Capacity
The expansion will introduce 200,000 sq. ft. of additional space, addressing the growing demand for Grade-A facilities amid…
How does genetic polymorphism affect Alzheimer’s treatments?
This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and…
What are the challenges in signal management in pharmacovigilance?
The conversation delves into the complexities of signal management in the PV landscape, highlighting recent advancements and the…
CluePoints’ growth investment from EQT: What’s next?
CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical…
EMA’s new clinical trials guideline
This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9…
How will Thermo Fisher’s new EU Facility impact trials?
This expansion of Thermo Fisher’s clinical trial network in Europe will help foster global clinical trial innovation and…
Combogesic IV – a new era of opioid-free pain relief medication?
This new medication, approved by the US FDA in October 2023, combines 1,000 mg of acetaminophen and 300…
Lokavant unveils AI solution for clinical trial optimization at DIA
Spectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials…
How does genetic polymorphism affect Alzheimer’s treatments?
This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and…
How does genetic polymorphism affect Alzheimer’s treatments?
This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and…
Systech unveils game-changing turnkey solution for pharma rework and aggregation
In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and…
uMotif revolutionizing clinical trials with innovative eCOA solutions
However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two…
Creative Qinesca unveiled at DIA – a game changer
Promising to redefine the landscape with its latest solutions, the company hopes to take center stage, offering advancements…
GiftHealth’s vow to enhance patient outcomes
John Romano, president, and co-founder, shares exclusive insights into how these innovations are set to tackle industry challenges…
how CluePoints is transforming research
This was to discuss what they describe as the groundbreaking impact of their Sub-population Optimization & Modeling Solution…
path forward is giving sites their own log-in credentials
Advarra is set to reveal solutions tailored to address current challenges in the pharmaceutical and healthcare industries. With…
Lokavant unveils AI feasibility solution at DIA 2024
This innovative technology allows study teams to predict, optimize, and control trial timelines and costs in real-time, enabling…
A year of innovation: Roquette’s US center milestone
The center, envisioned as a hub for groundbreaking research and development in pharmaceutical sciences, has thus far successfully…
Is Stardog AI the cure for pharma batch delays?
Enter Stardog, an AI and data startup at the forefront of revolutionizing how drugs are brought to market.…
FDA and CluePoints agreement boosting clinical data quality
FDA and its stakeholders have a vested interest in ensuring the integrity of clinical trial data and the…
Revolutionizing drug development: AI’s game-changing potential
Christine Allen, a veteran with 25 years in drug formulation, is at the forefront of this breakthrough. She…
Enzene Bioscience’s creative approach to biosimilars
He says the strategic expansion into continuous manufacturing facilities aims to revolutionize the accessibility and affordability of life-saving…
Positive CHMP opinion for Mirum’s Livmarli in PFIC
This endorsement comes from the phase 3 March study showing a highly significant reduction in pruritus severity compared…
Shionogi expands infectious disease R&D to the US
The big announcement was made at the BIO International Convention, where top policy and health leaders gathered to…
Diane Lacroix on Clinical Trials Day
Diane shares her expert insights on how creative data solutions are transforming the landscape of clinical research, enhancing…
Revolutionizing drug development: AI’s game-changing potential
Christine Allen, a veteran with 25 years in drug formulation, is at the forefront of this breakthrough. She…
Greenphire wins big at the 2024 MedTech Breakthrough Award
The company says its mission is geared towards enhancing clinical research site performance and participant satisfaction. This prestigious…
UK’s Celadon shipping cannabis-based medicine to the US
Following the signing of an introductory sales contract with a long-established American business, Celadon has successfully shipped two…
Women in Science – this week Orla Cussen
Coming from Donegal in the northwest of Ireland, where there isn’t much industry to a more than 20…
biggest psychiatric breakthrough in 40 years
Cybin is driven by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches – developing…
Asahi Kasei’s $1.1 billion power move
This strategic acquisition, valued at approximately SEK 11.8 billion (around $1.1 billion), aims to make Calliditas a wholly…
how can pharma companies fight antimicrobial resistance?
According to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short,…
Bicycle Therapeutics balance sheet boosted by $555M
The recent financing boosts Bicycle Therapeutics’ balance sheet, bringing the pro forma cash position to approximately $1 billion.…
Atropos funding surge enhancing AI in healthcare
This funding surge comes as the company continues to advance the application of generative AI through its platform,…
Swixx Biopharma creating new breed of global pharma partners
It has achieved this with the acquisition of Pharma Consulting Group S.A., the holding company of Laboratorios Biopas…
Elinzanetant shows significant reduction in menopausal hot flashes
Detailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical &…
How has geopolitical tension created problems for life sciences?
She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare,…
Study digs deep on clinical trials to find out what sponsors want
The survey included 127 pharmaceutical sponsor respondents and 79 research site respondents, analyzing their perspectives working together on…
Clinical Trials Day – Praxis on putting people first
The association says the day (May 20) is a ‘joyful opportunity to pause in reflection, recognition, and admiration…
How is SamaCare reducing financial and patient burdens?
This round was led by new investor Questa Capital, with participation from existing investors Vive Collective and South…
How can One2Treat revolutionize clinical trial designs?
One2Treat aims to make the clinical trial process as seamless as possible and answered a number of the…
Startup facilitating catheter insertion by improving probe usability
Samuel Poulin, presented Install-VASc and shared his insights into another innovative project aimed at transforming ultrasound-guided catheter insertion,…
how can pharma companies fight antimicrobial resistance?
According to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short,…
How can One2Treat revolutionize clinical trial designs?
One2Treat aims to make the clinical trial process as seamless as possible and answered a number of the…
Pam Diamond – The Sound of Medicine
Here she explains all about the challenges and triumphs that saw her reach her position of chief medical…
How is SamaCare reducing financial and patient burdens?
This round was led by new investor Questa Capital, with participation from existing investors Vive Collective and South…
Durect’s hope for people with alcohol-related hepatitis
Durect Corporation is a late-stage biopharma company championing the development of epigenetic therapies to transform the treatment of…
Indica Labs gets FDA clearance for platform giving pathologists the best tools
This significant 510(k) clearance permits the use of HALO AP Dx in conjunction with the Hamamatsu NanoZoomerS360MD Slide…
How has geopolitical tension created problems for life sciences?
She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare,…
Novartis to showcase next-gen manufacturing solutions at BIO 2024
BPR: What new products or innovations is Novartis showcasing at BIO 2024 this year? At BIO 2024, Novartis…
ReciBioPharm seizes viral and nucleic acid therapeutics opportunity at BIO 2024
BPR: What new products or innovations is your company showcasing at BIO 24? This year, we’re showcasing our…
‘BIO is a very important convention for us’
BPR: What new products or innovations is Cytiva showcasing at BIO 2024 this year? BIO is a very…
Ecolab Life Sciences to showcase bioquell qube and more at BIO 2024
BPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year…
Showcasing innovation in cell line development technology
BPR: What new products or innovations is Abzena showcasing at BIO 2024 this year? Abzena has recently launched…
Elinzanetant shows significant reduction in menopausal hot flushes
Detailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical &…
Inceptua expands early access program for cefiderocol in Latin America
While antimicrobial resistance is on the rise, a greater number of people still succumb to infections caused by…
New drug offers safer, non-toxic alternative for pain relief
The drug, SRP-001’s promising results from its phase 1 trial were also published. The announcement was made by…
PrecisionLife and Metrodora Institute join forces
The goal is to propel clinical trials aimed at speeding-up the diagnosis and treatment of ME/CFS and long…
Study highlights lack of awareness of cholesterol-related cardiac risks
Presented at ISPOR 2024, the findings emphasize the need for integrating patient needs and preferences into strategies for…
Roquette’s new capsules – solving drug delivery issues
The company says its new product, built on its advanced Lycagel pea starch technology, offers manufacturers the freedom…
Oral drug for kidney disease launched in China by Everest Medicine
This official launch marks a significant advancement in patient care in mainland China, introducing a new era in…
Sanofi’s billion euro investment in France
This move is part of a larger €3.5 billion program within the country. The investment will be allocated…
AI platform to be used in fight against cancer
Brian Hashemi, executive chairman and CEO of Novigenix, and Sabine Tejpar, founder of the IMMUcan Consortium, are leading…
Has the battle against antipsychotic weight gain been won?
The Virginia-based company has revealed promising results from its phase 1b clinical trial assessing RDX-002, a novel small…
Owlstone Medical secures $6.5M for breath-based diagnostics
The money is to support the development of breath-based diagnostics for infectious diseases. The funding comprises a $5…
Montreal miniseries – startup AFX Medical’s brainchild
Yesterday, (April 29), during a packed program of events, OSP was invited to watch presentations from four startups…
Lonza unveils AI-powered route scouting service for small molecule development
This offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using…
Life sciences sector deserves a purposeful fit-to-fund programme
Titled ‘State of the Discovery Nation (SODN) 2024: Fostering a Dynamic, Sustainable Medicines Discovery Sector,’ the report published…
Shionogi pays Maze $150M to advance Pompe disease compound to trial
The agreement, announced today, underscores Shionogi’s dedication to expanding its pipeline in the rare disease domain. According to…
Development leap in addressing neurological conditions
This first-in-human study aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of NBI-1117567 in healthy adult participants.…
Is investing in mental health a smart business decision?
As Mental Health Awareness Week 2024 approaches, employers must recognize the power of data in improving staff wellbeing.…
Montreal’s Displaid – disrupting the cardiac landscape
This week the second in the series comes from Jonathan Boudreau, a co-founder of Displaid and a finalist…
From ninth grade biology to the STEM industry
Having been originally interested in engineering, she soon realized that path was not the best for the set…
Boehringer’s global health mission: Fighting C-R-M diseases
This initiative will integrate select Walgreens community pharmacies as clinical trial sites, focusing on phase 3 trials for…
PCI Pharma Services $100M capital investment fill finish project
The ongoing construction and validation activities mark a significant step in the company’s ambitious $100 million capital investment…
Elevating healthcare product launches through smart data
Inizio Engage, a life science consulting firm, is aiming to address this challenge through its data-driven and evidence-based…
An interview with LGM Pharma
LGM Pharma, under Raje’s visionary stewardship, has undergone a remarkable journey of expansion and transformation since its acquisition…
An improvement for lab rat welfare as Olden Labs says AI can help
Using artificial intelligence (AI), genetic engineering, and robotics, the company said it proudly introduces the world’s first automated…
Psychedelic hub offers course for professionals to develop in the field
Starting on May 27 in London, this practitioner program is designed for healthcare professionals and students in professional…
A look into Organon’s mission and vision
However, Canadian company Organon wants to change this, a spin off from Merck & Co., Inc., it has…
A look into Organon’s mission and vision
However, Canadian company Organon wants to change this, a spin off from Merck & Co., Inc., it has…
Owlstone Medical secures $6.5M for breath-based diagnostics
The money is to support the development of breath-based diagnostics for infectious diseases. The funding comprises a $5…
From banking to biotech – Renée Aguiar-Lucander’s unique path in science
BPR: Could you give us an overview of your work? I joined Calliditas Therapeutics as CEO in 2017,…
Montreal miniseries – startup AFX Medical’s brainchild
Yesterday, (April 29), during a packed program of events, OSP was invited to watch presentations from four startups…
Lonza unveils AI-powered route scouting service for small molecule development
This offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using…
Wendy Cheng on global AI regulation in pharmaceuticals
Wendy specializes in applying advanced methodologies to address complex healthcare research challenges and has used machine learning and…
Has the battle against antipsychotic weight gain been won?
The Virginia-based company has revealed promising results from its phase 1b clinical trial assessing RDX-002, a novel small…
‘We are all about making sterile supply simple’
BPR: What new products or innovations is your company showcasing at CPHI North America this year? We are…
Platform integrates formulation development and on-demand GMP manufacturing
OSP caught up with them before the event, which is taking place in the Pennsylvania Convention Center, Philadelphia,…
Potential for Astellas’ new prostate cancer drug with EC approval
“The extended approval allows enzalutamide to be administered either as monotherapy or in combination with androgen deprivation therapy…
Women in Science Wednesday – Karen Ooms’ journey to Quanticate
She works as joint chief operating officer at a specialist biometrics CRO called Quanticate where she looks after…
on industry trends and bringing new treatments to market
We caught up with the company once more and put a few more questions to CEO Sebastian Coppe…
An interview with LGM Pharma
LGM Pharma, under Raje’s visionary stewardship, has undergone a remarkable journey of expansion and transformation since its acquisition…
Elevating healthcare product launches through smart data
Inizio Engage, a life science consulting firm, is aiming to address this challenge through its data-driven and evidence-based…
WuXi AppTec strongly denies sharing clients’ data with Beijing
It has been widely reported that in early February US intelligence officials told senators working on a biotech…
Oncimmune ventures into age-related disease biomarker research
The company says its renowned ImmunoINSIGHTS platform is recognized for its prowess in antibody marker discovery and will…
Vivalink and RSRT to accelerate treatments for Rett syndrome
The collaboration marks a significant stride towards shifting symptom assessment paradigms in Rett syndrome through the use of…
Momentous CE marking for life-saving device
This achievement marks a significant milestone in the company’s journey, granting European Union medical providers access to a…
Ultrahuman launches US smart ring manufacturing facility
It is now poised to become the first facility in the United States dedicated to producing wearable rings.…
How Biosynth is coming to CPHI North America with an ‘even bigger toolbox’
BPR: What new products or innovations is your company showcasing at CPhI North America this year? With…
Adapting to regulatory shifts and market demand
BPR: Can you provide insights into any regulatory changes or compliance issues that are impacting your business? Our…
Growing mini trees – exploring QS-21, the vaccine adjuvant
We delved into the fascinating world of vaccine adjuvants, particularly focusing on QS-21, a purified plant extract derived…
Women in Science – Katrina Rice on making the world a little better
As chief delivery officer, biometrics services at eClinical Solutions, Katrina is driving clinical data transformation, and building a…
Test that can enhance the likelihood of identifying colorectal cancer produced by Mainz Biomed
Mainz Biomed has been manufacturing ColoAlert which is a non-invasive mt-stool DNA screening test designed for early detection…
Against animal testing in pharma? See what the industry says
The company said its project represents a significant investment of $200 million over the past four years, with…
Giving the gift of health by finding solutions to the cost and complexity of prescription drugs
The company was founded by healthcare technology startup veteran John Romano, and the company launched a pilot program…
LGM Pharma to meet growing demand in geriatric and pediatric areas
As the company will be attending CPhI North America, OSP caught up with Hamilton Lenox, senior vice president…
world’s fifth leading killer by 2040 if left untreated
Following on from this news, OSP put several questions to the pharma giant to dig deeper into the…
The doors have opened at Thermo Fisher Scientific’s new innovation hub
The state-of-the-art facility will be an innovation and co-creation/working lab that supports the creation, testing, and validation of…
Pharma embraces combined PV solutions IQVIA study reveals
In her current role as senior director of integrated pharmacovigilance (PV) solutions, she provides senior leadership and oversight…
A new weapon against gonorrhoea
These findings, set to be showcased at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global…
Qinecsa acquires Insife to elevate pharmacovigilance tech
This strategic move, the company says, aligns with Qinecsa’s vision to emerge as the premier provider of digital…
Charles River – looking for alternatives to animal testing
The project represents a significant investment of $200 million over the past four years, with an additional $300…
AstraZeneca’s Impact CKD study: Alarming projections for 2032
The study forecasts that by 2032, up to 16.5% of the population in these countries could suffer from…
The key to getting pharma trials up and running
OSP spoke to Frontsin about why the CROs are under greater pressure to deliver measurable results quickly at…
Rare primary immunodeficiency drug trial’s enrollment complete
Leniolisib, marketed as Joenja in the US, obtained FDA approval in March 2023 for treating APDS in adult…
Medicxi invests $40m in D3 Bio, enhancing oncology pipeline
The investment will accelerate the development of D3 Bio’s pipeline of oncology compounds, particularly its lead asset DS3-001.…
Andreas Raabe – carving out a niche for Adragos Pharma
Andreas Raabe, the visionary CEO behind Adragos Pharma, shares his insights into the company’s recent expansion and strategic…
Selkirk’s rises to manufacturing biologics challenges with expansion
Founded in 2018 by a group of industry veterans with diverse expertise, the company has swiftly carved a…